midazolam
Generic: midazolam hydrochloride
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
midazolam
Generic Name
midazolam hydrochloride
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
midazolam hydrochloride 2 mg/2mL
Manufacturer
Identifiers & Regulatory
Product NDC
76045-211
Product ID
76045-211_ec9c9aee-b95f-4645-bf17-df7f1e3967d3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203460
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2021-04-16
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76045211
Hyphenated Format
76045-211
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
midazolam (source: ndc)
Generic Name
midazolam hydrochloride (source: ndc)
Application Number
ANDA203460 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/2mL
Packaging
- 24 BLISTER PACK in 1 CARTON (76045-211-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-211-00) / 2 mL in 1 SYRINGE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "ec9c9aee-b95f-4645-bf17-df7f1e3967d3", "openfda": {"unii": ["W7TTW573JJ"], "rxcui": ["998211", "1551393", "1551395"], "spl_set_id": ["1cc9ba6e-fa1b-405e-9de8-720c567b2a73"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 BLISTER PACK in 1 CARTON (76045-211-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-211-00) / 2 mL in 1 SYRINGE, GLASS", "package_ndc": "76045-211-20", "marketing_start_date": "20210416"}], "brand_name": "Midazolam", "product_id": "76045-211_ec9c9aee-b95f-4645-bf17-df7f1e3967d3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "76045-211", "dea_schedule": "CIV", "generic_name": "Midazolam Hydrochloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Midazolam", "active_ingredients": [{"name": "MIDAZOLAM HYDROCHLORIDE", "strength": "2 mg/2mL"}], "application_number": "ANDA203460", "marketing_category": "ANDA", "marketing_start_date": "20210416", "listing_expiration_date": "20261231"}